Anagin's Unattributed Round

Anagin raised a round of funding on July 12, 2016.

Anagin is developing first-in-class novel targeted therapies for addressing pathologies associated with disrupted synaptic plasticity in the central nervous system leading to psychiatric diseases. Suc…

Articles about Anagin's Unattributed Round: